Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013

Clément Lingani1, Cassi Bergeron-Caron2, James M Stuart3

  • 1Inter-country Support Team for West Africa, World Health Organization, Ouagadougou, Burkina Faso.

Abstract

Insights

The enhanced meningitis surveillance system in Africa significantly reduced group A bacterial meningitis cases after the 2010 vaccine introduction. This system provides crucial epidemiological data for outbreak response and disease monitoring.

Area of Science:

  • Epidemiology
  • Infectious Disease Surveillance
  • Vaccinology

Background:

  • Enhanced meningitis surveillance network established in sub-Saharan Africa in 2003.
  • Network collects, disseminates, and utilizes district-level weekly meningitis incidence data.
  • 10 years of data analyzed, including introduction of the group A meningococcal conjugate vaccine, PsA-TT (MenAfriVac), in 2010.

Purpose of the Study:

  • Analyze 10 years of meningitis incidence and case fatality data from the enhanced surveillance network.
  • Evaluate the impact of the PsA-TT vaccine on meningitis epidemiology in the region.
  • Assess the utility of the surveillance system for outbreak response and epidemiological overview.

Main Methods:

  • Data extracted from surveillance bulletins and WHO database for 10 consistently reporting countries (2004-2013).
  • Data de-duplicated and reconciled.
  • Analysis focused on meningitis incidence and case fatality rates, particularly for Neisseria meningitidis serogroup A (NmA).

Main Results:

  • 341,562 suspected/confirmed cases reported over 10 years, with a peak in 2009 due to NmA meningitis.
  • Case fatality rate was lowest (5.9%) during the 2009 epidemic year.
  • NmA meningitis incidence rate decreased over 10-fold, from 0.27 to 0.02 per 100,000 between 2004-2010 and 2011-2013, respectively (P < .0001).

Conclusions:

  • The enhanced meningitis surveillance system effectively supports timely outbreak response.
  • The system provides a valuable global overview of meningitis epidemiology in the region, despite data limitations.
  • A dramatic reduction in NmA meningitis incidence was confirmed following the introduction of the PsA-TT vaccine.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
96
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
788
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
25